Formulary Chapter 1: Gastro-intestinal system - Full Chapter
|
01.02 |
Antispasmodics and other drugs altering gut motility |
|
|
|
Primary care guidance
|
|
01.02 |
Other antispasmodics |
|
|
Mebeverine (Fybogel® Mebeverine)

|
Non Formulary
|
|
Mebeverine (suspension)

|
Non Formulary
|
Mebeverine suspension is very expensive which precludes routine usage.
May be continued for existing patients only, consider moving to a formulary option at next review
|
Mebeverine modified release

|
Non Formulary
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
|
|